Another novel chimeric DNA vaccine generated using antigen-specific connective tissue growth factor lined and MSLN (CTGF/MSLN), then combined to immuno-modulators, showed a potent antitumor effect in MM [144]. This evidence concerns the gene CCN2 and Miyoshi myopathy.